Clinical Trial Update: A Phase I Safety, Pharmacokinetics and Pharmacodynamics Study of Recombinant Factor VIIa in Adult Patients With Hemophilia A or B [Phase 1]

View source ↗

Summary

A Phase I safety, pharmacokinetics and pharmacodynamics study of recombinant factor VIIa in adults with Hemophilia A or B; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• Recombinant Factor VIIa (recombinant activated factor VII)

Snippet

Sponsor: rEVO Biologics | Conditions: Hemophilia | Phase 1 | Status: COMPLETED